Masuda, N., Toi, M., Yamamoto, N., Iwata, H., Kuroi, K., 坂東, 裕子, Ohtani, S., Takano, T., Inoue, K., Yanagita, Y., Kasai, H., Morita, S., Sakurai, T., Ohno, S.
Breast Cancer
25
(4),
407-415,
2018-07
...Methods: We designed a randomised phase II, five-arm study to evaluate the efficacy and safety of lapatinib and trastuzumab (6 weeks) followed by lapatinib and trastuzumab plus weekly paclitaxel (12 weeks...
機関リポジトリ
HANDLE
HANDLE
ほか1件